Q&A: As RSV vaccine approvals loom, regulators need to devise vaccination strategies
Pharmaceutical Technology
MAY 1, 2023
After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May.
Let's personalize your content